Catherine Mackey J.'s Insider Trades & SAST Disclosures

Catherine Mackey J.'s most recent trade in Avid Bioservices Inc was a trade of 26,756 Common Stock, $0.001 par value done . Disclosure was reported to the exchange on Dec. 14, 2024.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Avid Bioservices Inc
Catherine J. Mackey Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2024 26,756 43,379 (0%) 0% - Common Stock, $0.001 par value
Avid Bioservices Inc
Catherine J. Mackey Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2024 26,756 0 - - Restricted Stock Units
Avid Bioservices Inc
Catherine J. Mackey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2024 8,147 8,147 - - Restricted Stock Units
Voyager Therapeutics Inc
Catherine J. Mackey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Jun 2024 24,000 24,000 - - Stock Option (Right to Buy)
Ideaya Biosciences Inc
Catherine J. Mackey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 May 2024 16,200 16,200 - - Stock Option (right to buy)
Avid Bioservices Inc
Mackey J. Catherine Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2023 26,756 26,756 - - Restricted Stock Units
Avid Bioservices Inc
Catherine Mackey J. Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2023 9,612 0 - - Restricted Stock Units
Avid Bioservices Inc
J. Catherine Mackey Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2023 9,612 16,623 (0%) 0% - Common Stock, $0.001 par value
Ideaya Biosciences Inc
Catherine J. Mackey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Jun 2023 16,200 16,200 - - Stock Option (right to buy)
Voyager Therapeutics Inc
Catherine J. Mackey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jun 2023 22,000 22,000 - - Stock Option (Right to Buy)
Voyager Therapeutics Inc
Catherine J. Mackey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Aug 2022 44,000 44,000 - - Stock Option (Right to Buy)
Ideaya Biosciences Inc
Catherine J. Mackey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Apr 2022 22,000 22,000 - - Stock Option (Right to Buy)
Avid Bioservices Inc
Catherine J. Mackey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2021 4,632 4,632 - - Restricted Stock Units
Avid Bioservices Inc
Catherine J. Mackey Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2021 2,379 2,379 (0%) 0% - Common Stock, $0.001 par value
Avid Bioservices Inc
Catherine J. Mackey Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2021 2,379 0 - - Restricted Stock Units
Avid Bioservices Inc
Catherine J. Mackey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2020 10,030 61,805 - - Stock Option (right to buy)
Avid Bioservices Inc
Catherine J. Mackey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2020 2,379 2,379 - - Restricted Stock Units
Poseida Therapeutics Inc
Catherine J. Mackey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Jul 2020 20,000 20,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades